Ross Weinreb
Stock Analyst at Goldman Sachs
(n/a)
# 4,351
Out of 4,714 analysts
3
Total ratings
n/a
Success rate
-45.51%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ross Weinreb
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RLMD Relmada Therapeutics | Maintains: Buy | $69 → $53 | $0.47 | +11,174.20% | 3 | Mar 24, 2022 |
Relmada Therapeutics
Mar 24, 2022
Maintains: Buy
Price Target: $69 → $53
Current: $0.47
Upside: +11,174.20%